z-logo
open-access-imgOpen Access
Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
Author(s) -
Van Thuan Hoang
Publication year - 2021
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2021.02.079
Subject(s) - hydroxychloroquine , covid-19 , medicine , scopus , mortality rate , pediatrics , disease , medline , virology , infectious disease (medical specialty) , outbreak , law , political science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom